Evidence for preventing infection in abortion care

Janesh Gupta; C Williams

doi:10.1080/13625180701536698

Evidence for preventing infection in abortion care

Janesh Gupta
, C Williams

Research output: Contribution to journal › Article

1 Citation (Scopus)

Abstract

There is controversy of whether prophylaxis treatment or a ''screen and treat'' policy should be adopted for preventing infective complications when women undergo abortion. There is currently compelling evidence that indicates that a universal policy of prophylaxis treatment to all women undergoing abortion should receive antibiotics. It is also a cost-effective policy.

Original language	English
Pages (from-to)	191-3
Number of pages	3
Journal	The European Journal of Contraception and Reproductive Health Care
Volume	12
DOIs	https://doi.org/10.1080/13625180701536698
Publication status	Published - 1 Jan 2007

Access to Document

10.1080/13625180701536698

Cite this

@article{2c3373336d8c42d0ae7a0dfa2d5cd3f6,

title = "Evidence for preventing infection in abortion care",

abstract = "There is controversy of whether prophylaxis treatment or a ''screen and treat'' policy should be adopted for preventing infective complications when women undergo abortion. There is currently compelling evidence that indicates that a universal policy of prophylaxis treatment to all women undergoing abortion should receive antibiotics. It is also a cost-effective policy.",

author = "Janesh Gupta and C Williams",

year = "2007",

month = jan,

day = "1",

doi = "10.1080/13625180701536698",

language = "English",

volume = "12",

pages = "191--3",

journal = "The European Journal of Contraception and Reproductive Health Care",

issn = "1473-0782",

publisher = "Taylor \& Francis",

}

TY - JOUR

T1 - Evidence for preventing infection in abortion care

AU - Gupta, Janesh

AU - Williams, C

PY - 2007/1/1

Y1 - 2007/1/1

N2 - There is controversy of whether prophylaxis treatment or a ''screen and treat'' policy should be adopted for preventing infective complications when women undergo abortion. There is currently compelling evidence that indicates that a universal policy of prophylaxis treatment to all women undergoing abortion should receive antibiotics. It is also a cost-effective policy.

AB - There is controversy of whether prophylaxis treatment or a ''screen and treat'' policy should be adopted for preventing infective complications when women undergo abortion. There is currently compelling evidence that indicates that a universal policy of prophylaxis treatment to all women undergoing abortion should receive antibiotics. It is also a cost-effective policy.

U2 - 10.1080/13625180701536698

DO - 10.1080/13625180701536698

M3 - Article

C2 - 17763256

SN - 1473-0782

VL - 12

SP - 191

EP - 193

JO - The European Journal of Contraception and Reproductive Health Care

JF - The European Journal of Contraception and Reproductive Health Care

ER -

Evidence for preventing infection in abortion care

Abstract

Access to Document

Fingerprint

Cite this